Truvestments Capital LLC Makes New $32,000 Investment in Sensus Healthcare, Inc. (NASDAQ:SRTS)

Truvestments Capital LLC bought a new position in Sensus Healthcare, Inc. (NASDAQ:SRTS) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 5,511 shares of the company’s stock, valued at approximately $32,000.

A number of other institutional investors have also modified their holdings of SRTS. Chapin Davis Inc. acquired a new stake in shares of Sensus Healthcare during the 2nd quarter valued at approximately $53,000. Sachetta LLC raised its holdings in shares of Sensus Healthcare by 12.9% during the second quarter. Sachetta LLC now owns 118,354 shares of the company’s stock worth $631,000 after purchasing an additional 13,544 shares during the period. XTX Topco Ltd acquired a new stake in shares of Sensus Healthcare during the second quarter worth $95,000. Cubist Systematic Strategies LLC bought a new position in shares of Sensus Healthcare in the 2nd quarter worth about $156,000. Finally, Acadian Asset Management LLC boosted its holdings in shares of Sensus Healthcare by 578.6% in the 2nd quarter. Acadian Asset Management LLC now owns 45,124 shares of the company’s stock valued at $239,000 after buying an additional 38,474 shares during the period. Institutional investors and hedge funds own 25.30% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. Maxim Group raised their target price on shares of Sensus Healthcare from $12.00 to $14.00 and gave the stock a “buy” rating in a report on Friday, November 15th. HC Wainwright raised their price target on Sensus Healthcare from $10.00 to $11.00 and gave the stock a “buy” rating in a report on Monday, November 18th.

Sensus Healthcare Stock Performance

Sensus Healthcare stock opened at $8.60 on Thursday. The firm has a market capitalization of $140.95 million, a P/E ratio of 15.09 and a beta of 1.04. The company has a 50-day simple moving average of $6.80 and a 200-day simple moving average of $6.22. Sensus Healthcare, Inc. has a one year low of $2.05 and a one year high of $9.33.

Sensus Healthcare Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.